DAVIE JOSEPH MD PHD 4
4 · CV THERAPEUTICS INC · Filed Apr 16, 2009
Insider Transaction Report
Form 4
DAVIE JOSEPH MD PHD
Director
Transactions
- Exercise/Conversion
Nonqualified Stock Option (right to buy)
2009-04-14$11.26/sh−2,500$28,150→ 0 totalExercise: $8.74From: 2008-06-20Exp: 2018-05-20→ Common Stock (2,500 underlying)
Footnotes (1)
- [F1]This option to purchase shares of the Issuer's stock, which provided that 8.33% of the shares subject to the option shall vest per month over the 12 month period following the May 20, 2008 date of grant, became 100% vested and exercisable due to a change in control of the Issuer effected through the tender offer by Apex Merger Sub, Inc. ("Apex"), a wholly owned subsidiary of Gilead Sciences, Inc. ("Gilead), effective as of April 14, 2009. The Issuer will make a cash payment of $21,150, representing the gross cash amount for the remaining shares subject to this option which became 100% vested and exercisable due to the change in control, to the Reporting Party.